Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial
Vinit B. Mahajan, Byron L. Lam, Ananta Ayyagari, Allen C. Ho et al.
Citations
3 citations
Journal
EClinicalMedicine
Topics
Retinal Development and Disorders
Field-Weighted Citation Impact (FWCI)
2.42
article
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial
Vinit B. Mahajan, Byron L. Lam, Ananta Ayyagari, Allen C. Ho, Najam A. Sharif, Stephen H. Tsang, Víctor H. González, Sai H. Chavala, Mark Von Tress, David S. Boyer, Harlan Lane, Ninel Z. Gregori, Subrata Batabyal, Jody R. Piltz‐Seymour, Samarendra Mohanty, John M Koester, Sang Hoon Kim, Nozhat Choudry, Jean Chang, Samuel B. Barone, Michael Carlson, Vitaliy Zak
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
EClinicalMedicineVol. 87
Institutions
University of Miami (US), Texas Oncology (US), Cook Children's Medical Center (US), Palo Alto Institute (US), Retina Vitreous Associates Medical Group (US), Valley Retina Institute (US), Texas Instruments (United States) (US), Columbia University (US), Wills Eye Hospital (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial — Vinit B. Mahajan, Byron L. Lam, et al. · EClinicalMedicine (2025) | TGRS Research Map | TGRS